Oculopharyngeal muscular dystrophy
- PMID: 10711989
- DOI: 10.1055/s-2008-1040826
Oculopharyngeal muscular dystrophy
Abstract
Autosomal dominant oculopharyngeal muscular dystrophy (OPMD) is an adult-onset disease with worldwide distribution. It usually presents in the fifth or sixth decades with progressive dysphagia, eyelid ptosis, and proximal limb weakness. Unique intranuclear filament inclusions in skeletal muscle fibers are its morphological hallmark. Surgical correction of the ptosis and cricopharyngeal myotomy are the only therapies available. Autosomal dominant OPMD is caused by short (GCG)8-13 riplet-repeat expansions in the polyadenylation binding protein 2 (PABP2) gene, which is localized in chromosome 14q11. Autosomal recessive OPMD is caused by a double dose of a (GCG)7 PABP2 allele. The GCG expansions cause lengthening of a predicted polyalanine tract in the protein. The expanded polyalanine domains may cause polyalanine nuclear toxicity by accumulating as nondegradable nuclear filaments.
Similar articles
-
[From gene to disease; the PABN1 gene and oculopharyngeal muscular dystrophy].Ned Tijdschr Geneeskd. 2006 May 20;150(20):1124-6. Ned Tijdschr Geneeskd. 2006. PMID: 16756225 Review. Dutch.
-
Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy.Nat Genet. 1998 Feb;18(2):164-7. doi: 10.1038/ng0298-164. Nat Genet. 1998. PMID: 9462747
-
PABP2 polyalanine tract expansion causes intranuclear inclusions in oculopharyngeal muscular dystrophy.Ann Neurol. 2000 Nov;48(5):798-802. Ann Neurol. 2000. PMID: 11079546
-
[Oculopharyngeal muscular dystrophy: study of patients from seven Spanish families with different GCG expansions in PABP2 gene].Neurologia. 2004 Jun;19(5):239-47. Neurologia. 2004. PMID: 15150706 Spanish.
-
Oculopharyngeal muscular dystrophy: a late-onset polyalanine disease.Cytogenet Genome Res. 2003;100(1-4):252-60. doi: 10.1159/000072861. Cytogenet Genome Res. 2003. PMID: 14526187 Review.
Cited by
-
The phenotypic and genotypic features of Chinese patients with oculopharyngeal muscular dystrophy.Ann Clin Transl Neurol. 2023 Mar;10(3):426-439. doi: 10.1002/acn3.51733. Epub 2023 Jan 23. Ann Clin Transl Neurol. 2023. PMID: 36691350 Free PMC article.
-
Lithium chloride attenuates cell death in oculopharyngeal muscular dystrophy by perturbing Wnt/β-catenin pathway.Cell Death Dis. 2013 Oct 3;4(10):e821. doi: 10.1038/cddis.2013.342. Cell Death Dis. 2013. PMID: 24091664 Free PMC article.
-
Hsp70 chaperones and type I PRMTs are sequestered at intranuclear inclusions caused by polyalanine expansions in PABPN1.PLoS One. 2009 Jul 29;4(7):e6418. doi: 10.1371/journal.pone.0006418. PLoS One. 2009. PMID: 19641605 Free PMC article.
-
Valproic acid is protective in cellular and worm models of oculopharyngeal muscular dystrophy.Neurology. 2018 Aug 7;91(6):e551-e561. doi: 10.1212/WNL.0000000000005942. Epub 2018 Jul 13. Neurology. 2018. PMID: 30006409 Free PMC article.
-
Exploring the Potential of Small Molecule-Based Therapeutic Approaches for Targeting Trinucleotide Repeat Disorders.Mol Neurobiol. 2020 Jan;57(1):566-584. doi: 10.1007/s12035-019-01724-4. Epub 2019 Aug 9. Mol Neurobiol. 2020. PMID: 31399954 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
